Sporadic Amplification of the Insulin-like Growth Factor 1 Receptor Gene in Human Breast Tumors

Cancer Research

Volumn 52, Issue 4, 1992, Pages 1036-1039

  Berns, Els M J J ^a   Klijn, Jan G M ^a   van Staveren, Iris L ^a   Portengen, Henk ^a   Foekens, John A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER SURVIVAL; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BLOTTING, SOUTHERN; BREAST NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; HUMAN; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGE; PROGNOSIS; PROTO-ONCOGENES; RECEPTORS, CELL SURFACE; RECEPTORS, SOMATOMEDIN; SUPPORT, NON-U.S. GOV'T;

EID: 0026605211     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Furlanelto, R. W., and Dicarlo. J. N. Somatomedin-C receptors and growth effects in human breast cancer cells maintained in long term tissue culture. Cancer Res., 44: 2122-2128, 1984.
2. Foekens, J. A., Portengen, H., Janssen. M., and Klijn J. G. M. Insulin-like growth factor 1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer. Cancer (Phila.), 63: 2139-2147, 1989.
3. Peyrat, J-P., Bonneterre, J., Vennin, P. H., Jammes H., Beuscart, R., Hecquet, B., Djiane. J., Lefebre, J., and Dmaille.A. Insulin-like growth factor 1 receptors (IGF-l-R) and IGF-1 in human breast tumors. J. Steroid Biochem. Mol. Biol., 37: 823-827. 1990.
4. Chernausck, S. D., Jacobs. S., and Van Wyk, J. J. Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling. Biochemistry, 20: 7345-7350, 1981.
5. Jacobs, S., Kull, F. C., Earo. H. S., Svoboda. M. E., Van Wyk, J. J., and Cuatrecasas, P. Somatomedin-C stimulates the phosphorylation of the rfsubunit of its own receptor. J. Biol. Chem., 25:9581-9584, 1983.
6. Ullrich, A., Gray, A., Tarn, A. W., Yang-Feng, T., Tsubokawa. M., Collins, C., Henzel, W., Le Bon, T., Kathuria, S., Chen, E., Francke, LI., Ramachandran, J., and Fujita-Yamaguchi. Y. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural de terminants that define functional specificity. EMBO J., 5: 2503-2512, 1986.
7. Pekonen, F., Partanen. S., Makinen, T., and Rutanen, E. M. Receptors for epidermal growth factor and insulin-like growth factor 1 and their relation to steroid receptors in human breast cancer. Cancer Res., 48: 1343-1347, 1988.
8. Peyrat. J-P., Bonneterre, J., Beuscart. R., Djiane. J., and Dmaille, A. Insulinlike growth factor-1 receptors (IGF-l-R) in human breast cancer. Relation to estradici and progesterone receptors. Cancer Res., 48: 6429-6433, 1988.
9. Foekens, J. A., Portengen, Hvan Putten, W. L. J., Trapman, A. M. A. C. Reubi, J-C. Alexieva-Figusch. J., and Klijn, J. G. M. Prognostic value of receptors for insulin-like growth factor-1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Res., 49: 7002-7009, 1989.
10. Foekens, J. A., Van Putten, W. L. J., Portengen. H., Rodcnburg, C. J., Reubi. J-C. Berns. P. M. J. J., Henzen-Logmans. S., Van der Burg, M. E. L., Alexieva-Figusch, J., and Klijn. J. G. M. Prognostic value of pS2 protein and receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF-l-R). and somatostatin (SS-R) in patients with breast and ovarian cancer. J. Steroid Biochem. Mol. Biol., 37: 815-821, 1990.
11. Peyrat, J-P., Bonneterre, J., Laurent, J. C., Louchez. M. M., Armani, S., Leroy-Martin, B., Vilian, M. O., Delobelle, A., and Dmaille, A. Presence and characterization of insulin-like growth factor-1 receptors in human benign breast disease. Eur. J. Cancer Clin. Oncol., 24: 1425-1431. 1988.
12. Callahan, R. Genetic alterations in primary breast cancer. Breast Cancer Res. Treat. 13: 191-203, 1989.
13. Klijn, J. G. M., Berns, P. M. J. J., Schmilz, P. I. M., and Foekens, J. A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev., in press, 1992.
14. EORTC Breast Cancer Cooperative Group. Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur. J. Cancer., 16: 1513-1515. 1980.
15. Foekens, J. A., Portengen. H., van Putten, W. L. J., Peters. H. A., Krijnen, H. L. J. M., Alexieva-Figusch. J., and Klijn. J. G. M. Prognostic value of estrogen and progesterone receptors measured by enzyme-immunoassays in human breast tumor cytosols. Cancer res., 49: 7002-7009, 1989.
16. Davis, L. G., Dibner. M. D., and Battey, J. F. Basic Methods in Molecular Biology. New York: Elsevier, 1986.
17. Berns, E. M. J. J., Klijn, J. G. M., van Stavercn, I. L., Portengen. H., Noordegraaf, E., and Foekens, J. A. Prevalence of amplification of the oncogenes c-myc, HER2/neu, and int-2 in thousand human breast tumours: correlation with steroid receptors. Eur. J. Cancer, in press, 1992.
18. Saint-Ruf, C., Gerbault-Seureau, M., Viegas-Pequignot. E., Zafrani, B., Cassingena, R., and Dutrillaux, B. Proto-oncogene amplification and ho mogeneously stained regions in human breast carcinomas. Genes Chromo somes Cancer, 2: 18-26, 1990.
19. Borg. A., Sigurdsson, H., Clark, G. M., Perno, M., Fuqua, S. A. W., Olsson, H., Killandcr, D., and McGuire, W. L. Association of int-2/hst-\ coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer, 63: 136-142, 1991.
20. Bonneterre. J., Peyrat, J-P., Beuscart, R., and Dmaille. A. Prognostic significance of IGF-1-receptors in human breast cancer. Cancer Res., 50: 6931-6935, 1990.